BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34768771)

  • 1. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
    Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
    Lachén-Montes M; González-Morales A; Schvartz D; Zelaya MV; Ausin K; Fernández-Irigoyen J; Sánchez JC; Santamaría E
    J Proteomics; 2019 Jun; 201():37-47. PubMed ID: 30999060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
    Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
    Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes.
    Lachén-Montes M; Íñigo-Marco I; Cartas-Cejudo P; Fernández-Irigoyen J; Santamaría E
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
    Lachén-Montes M; González-Morales A; Iloro I; Elortza F; Ferrer I; Gveric D; Fernández-Irigoyen J; Santamaría E
    Neurobiol Aging; 2019 Jan; 73():123-134. PubMed ID: 30342273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
    Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.
    Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
    Lengacher NA; Tomlinson JJ; Jochum AK; Franz J; Hasan Ali O; Flatz L; Jochum W; Penninger J; ; Stadelmann C; Woulfe JM; Schlossmacher MG
    Acta Neuropathol Commun; 2024 May; 12(1):70. PubMed ID: 38698465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
    Lachen-Montes M; Zelaya MV; Segura V; Fernández-Irigoyen J; Santamaría E
    Oncotarget; 2017 Sep; 8(41):69663-69679. PubMed ID: 29050232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
    Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
    Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies.
    Lachén-Montes M; Mendizuri N; Schvartz D; Fernández-Irigoyen J; Sánchez JC; Santamaría E
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.
    Mundiñano IC; Hernandez M; Dicaudo C; Ordoñez C; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2013 Sep; 126(3):411-25. PubMed ID: 23784261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic Analysis of the Human Olfactory Bulb.
    Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
    OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.